In addition, RHAMM is related to worse clinical outcomes of human malignancies, including endometrial cancer, oral squamous cell carcinoma, prostate cancer [11,12,13], as well as breast cancer [14,15,16]. This evidence concerns the gene HMMR and breast carcinoma.